You are trying to reach document intended for healthcare professionals only
Letters to HCPs
Valproate DHPC - letter for HCPs UK - PASS Paternal
For Healthcare Professionals
New measures regarding the potential risk of neurodevelopmental disorders in children of fathers treated with valproate in the 3 months prior to conception